X-Trade Brokers Dom Maklerski S.A.
Standalone financial statements for 2020
(Translation of a document originally issued in Polish)
www.xtb.pl 16
Pursuant to IFRS 13 “Fair Value Measurement”, the Company uses valuation techniques that are appropriate in the
circumstances and for which sufficient data are available to measure fair value, maximising the use of relevant observable
inputs and minimizing the use of unobservable inputs, namely:
1. valuation based on the data fully observable (active market quotations);
2. valuation models using information which does not constitute the data from Level 1, but observable, either directly or
indirectly;
3. valuation models using unobservable data (not derived from an active market).
Valuation techniques used to determine fair value are applied consistently. Change in valuation techniques resulting in a
transfer between these methods occurs when:
• transfer from Method 1 to 2 takes place when, for financial instruments measured using Method 1, quoted prices from an
active market are not available at the balance sheet date (and they used to be);
• transfer from Method 2 to 3 takes place when, for financial instruments measured using Method 2, the value of parameters
not derived from the market has become material at a given balance sheet date (and it used to be immaterial).
4.3.6 Impairment of financial assets
Financial assets, aside from those carried at fair value through profit or loss, are tested for impairment at every balance sheet
date. Financial assets are impaired when there is objective evidence that the events which occurred after initial recognition of
the asset have an adverse impact on the estimated future cash flows of the given financial assets.
Concerning listed stock classified as available for sale, a material or long-term decline in share prices is considered to be
objective evidence of impairment.
For certain categories of financial assets, e.g. trade receivables, specific assets which are not considered past due, are tested
for impairment cumulatively. Objective evidence of impairment of a portfolio of receivables includes the Company’s experience
in collecting receivables; increase in the number of payments past due by 90 days on average and observable changes in the
domestic or local economic environment which are connected with cases of the untimely payment of liabilities.
In case of some categories of financial assets, for example trade receivables, particular assets assessed as not overdue are
tested for impairment together. Objective evidence of impairment for the receivables portfolio includes the Company's
experience in the debt collection process; increase in the number of late payments exceeding an average of 90 days as well as
observed changes in the conditions of the national or local economy which are connected with cases of untimely repayment of
receivables.
At each reporting date, an entity measures the loss allowance for a financial instrument at an amount equal to the lifetime
expected credit losses if the credit risk on that financial instrument has increased significantly since initial recognition. At each
reporting date, an entity assesses whether the credit risk on a financial instrument has increased significantly since initial
recognition. When making the assessment, an entity uses the change in the risk of a default occurring over the expected life of
the financial instrument instead of the change in the amount of expected credit losses. To make that assessment, an entity
compares the risk of a default occurring on the financial instrument as at the reporting date with the risk of a default occurring
on the financial instrument as at the date of initial recognition and consider reasonable and supportable information, that is
available without undue cost or effort, that is indicative of significant increases in credit risk since initial recognition.
4.3.7 Derecognition of financial assets from the balance sheet
The Company derecognises a financial asset from the balance sheet only when contractual rights to cash flows generated by
the asset expire or when the financial asset with essentially all risks and rewards of ownership of such asset is transferred to
another entity. If the Company does not transfer or retain essentially all risks and rewards of ownership of such asset, and
continues to control it, the Company recognises the retained share in such asset and related liabilities under payments due, if
any. If, in turn, the Company retains essentially all the risks and benefits of the asset transferred, it continues to recognise the
relevant financial asset. At the time of derecognising a financial asset in full, the difference between (i) the carrying amount and
(ii) the sum of payment received and any accumulated gains or losses entered under other comprehensive income, is
recognised under the income or expenses for the period.